NasdaqGM - Nasdaq Real Time Price USD

Phibro Animal Health Corporation (PAHC)

Compare
20.05
-1.43
(-6.66%)
At close: January 10 at 4:00:00 PM EST
20.05
0.00
(0.00%)
After hours: January 10 at 4:01:40 PM EST

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jack Clifford Bendheim Chairman, President & CEO 3.96M -- 1947
Mr. Glenn C. David Chief Financial Officer 416.8k -- 1972
Mr. Larry L. Miller Chief Operating Officer 2.13M -- 1964
Mr. Daniel M. Bendheim J.D. Executive VP of Corporate Strategy & Director 763.24k -- 1972
Mr. Rob Aukerman Advisor 752.7k -- 1958
Ms. Judith A. Weinstein Senior VP, General Counsel & Corporate Secretary -- -- 1969
Ms. Lisa A. Escudero Senior Vice President of Human Resources -- -- 1962
Mr. Jonathan Bendheim President of MACIE Region, GM of Israel Operations & Director -- -- 1976
Mr. Ramon Fuenmayor President South America Region -- -- --
Mr. Samson Li President of Asia Pacific Region -- -- 1972

Phibro Animal Health Corporation

Glenpointe Centre East
3rd Floor Suite 21 300 Frank West Burr Boulevard
Teaneck, NJ 07666-6712
United States
201 329 7300 https://www.pahc.com
Sector: 
Healthcare
Full Time Employees: 
1,940

Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Corporate Governance

Phibro Animal Health Corporation’s ISS Governance QualityScore as of January 1, 2025 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 10; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 5, 2025 at 9:00 PM UTC - February 10, 2025 at 9:00 PM UTC

Phibro Animal Health Corporation Earnings Date

Recent Events

January 7, 2025 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

December 18, 2024 at 12:00 AM UTC

Dividend Date

November 27, 2024 at 12:00 AM UTC

Ex-Dividend Date

November 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 7, 2024 at 2:00 PM UTC

Q1 2025 Earnings Call

November 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 31, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 20, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

August 28, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers